bioAffinity Technologies, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
bioAffinity Technologies, Inc. (BIAF) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.34 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.46M shares, a 222.95% increase year-over-year.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 452.91K shares, a 95.36% decline year-over-year.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 9.76M shares, a 78.79% increase year-over-year.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 5.46M shares, a 12.13% decline year-over-year.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.46M shares, a 239.42% increase from fiscal 2024.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 431.13K shares, a 91.92% decline from fiscal 2023.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.33M shares, a 2.25% decline from fiscal 2022.
- bioAffinity Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.46M shares, a 7.25% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.34M shares 10-Q · filed 2026-08-07 | |||||||
| 2026-03-31 | 1.46M shares 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | 1.46M shares 10-K · filed 2026-03-16 | |||||||
| 2025-09-30 | 1.47M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 452.91K shares 10-Q · filed 2026-08-07 | 28.78M shares 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | 452.91K shares 10-Q · filed 2026-05-11 | 13.61M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 431.13K shares 10-K · filed 2026-03-16 | 12.95M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 308.66K shares 10-Q · filed 2025-11-14 | 10.33M shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 9.42M shares 10-Q · filed 2025-08-14 | 9.18M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 9.76M shares 10-Q · filed 2025-05-15 | 9.46M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 5.33M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 5.47M shares 10-Q · filed 2024-11-14 | 5.33M shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 5.46M shares 10-Q · filed 2024-08-14 | 5.56M shares 10-Q · filed 2023-08-14 | ||||||
| 2023-03-31 | 5.46M shares 10-Q · filed 2024-05-15 | 5.56M shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 5.46M shares 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | 5.51M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 6.27M shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 6.21M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 5.88M shares 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | 3.18M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |